These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 2450950)
21. Protective immunity to the group A Streptococcus may be only strain specific. de Malmanche SA; Martin DR Med Microbiol Immunol; 1994 Dec; 183(6):299-306. PubMed ID: 7596313 [TBL] [Abstract][Full Text] [Related]
22. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. Whitnack E; Beachey EH J Exp Med; 1985 Dec; 162(6):1983-97. PubMed ID: 3906018 [TBL] [Abstract][Full Text] [Related]
24. A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine. Shikhman AR; Greenspan NS; Cunningham MW J Immunol; 1993 Oct; 151(7):3902-13. PubMed ID: 7690820 [TBL] [Abstract][Full Text] [Related]
25. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Dale JB; Washburn RG; Marques MB; Wessels MR Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352 [TBL] [Abstract][Full Text] [Related]
26. Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies. Dale JB; Beachey EH Infect Immun; 1984 Oct; 46(1):267-9. PubMed ID: 6207110 [TBL] [Abstract][Full Text] [Related]
27. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Dale JB Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154 [TBL] [Abstract][Full Text] [Related]
28. Group A streptococcus expresses a trio of surface proteins containing protective epitopes. Niedermeyer SE; Penfound TA; Hohn C; Li Y; Homayouni R; Zhao J; Dale JB Clin Vaccine Immunol; 2014 Oct; 21(10):1421-5. PubMed ID: 25080552 [TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody to human renal glomeruli cross-reacts with streptococcal M protein. Goroncy-Bermes P; Dale JB; Beachey EH; Opferkuch W Infect Immun; 1987 Oct; 55(10):2416-9. PubMed ID: 2443450 [TBL] [Abstract][Full Text] [Related]
30. Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. Scott JR; Guenthner PC; Malone LM; Fischetti VA J Exp Med; 1986 Nov; 164(5):1641-51. PubMed ID: 3534131 [TBL] [Abstract][Full Text] [Related]
31. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210 [TBL] [Abstract][Full Text] [Related]
32. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera. VillaseƱor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949 [TBL] [Abstract][Full Text] [Related]
33. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections. Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118 [TBL] [Abstract][Full Text] [Related]
34. Recombinant tetravalent group A streptococcal M protein vaccine. Dale JB; Chiang EY; Lederer JW J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202 [TBL] [Abstract][Full Text] [Related]
35. Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Salehi S; Hohn CM; Penfound TA; Dale JB mSphere; 2018 Dec; 3(6):. PubMed ID: 30567901 [TBL] [Abstract][Full Text] [Related]
36. Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Hayman WA; Toth I; Flinn N; Scanlon M; Good MF Immunol Cell Biol; 2002 Apr; 80(2):178-87. PubMed ID: 11940119 [TBL] [Abstract][Full Text] [Related]
37. Mapping T-cell epitopes in group A streptococcal type 5 M protein. Robinson JH; Atherton MC; Goodacre JA; Pinkney M; Weightman H; Kehoe MA Infect Immun; 1991 Dec; 59(12):4324-31. PubMed ID: 1718873 [TBL] [Abstract][Full Text] [Related]
38. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Hayman WA; Brandt ER; Relf WA; Cooper J; Saul A; Good MF Int Immunol; 1997 Nov; 9(11):1723-33. PubMed ID: 9418133 [TBL] [Abstract][Full Text] [Related]
39. Protective immunity evoked by synthetic peptides of streptococcal M proteins. Beachey EH Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199 [No Abstract] [Full Text] [Related]
40. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis. Jacks-Weis J; Kim Y; Cleary PP J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]